MARKET

CNTB

CNTB

Connect Biopharma Holdings Ltd
NASDAQ
0.7610
-0.0414
-5.16%
After Hours: 0.8000 +0.039 +5.12% 16:59 05/13 EDT
OPEN
0.8100
PREV CLOSE
0.8024
HIGH
0.8249
LOW
0.7600
VOLUME
63.73K
TURNOVER
--
52 WEEK HIGH
2.080
52 WEEK LOW
0.5100
MARKET CAP
42.12M
P/E (TTM)
-2.6890
1D
5D
1M
3M
1Y
5Y
1D
Connect Biopharma Launches Phase 2 Asthma Study
TipRanks · 1d ago
Connect Biopharma initiates Phase 2 Seabreeze STAT Asthma study
TipRanks · 1d ago
CONNECT BIOPHARMA HOLDINGS LTD: EXPECT TO REPORT TOPLINE DATA FROM SEABREEZE STAT ASTHMA STUDY IN 1H 2026
Reuters · 1d ago
CONNECT BIOPHARMA INITIATES PHASE 2 SEABREEZE STAT ASTHMA STUDY EVALUATING RADEMIKIBART FOR THE TREATMENT OF ACUTE EXACERBATIONS IN ASTHMA
Reuters · 1d ago
Weekly Report: what happened at CNTB last week (0505-0509)?
Weekly Report · 2d ago
Weekly Report: what happened at CNTB last week (0428-0502)?
Weekly Report · 05/05 11:54
Weekly Report: what happened at CNTB last week (0421-0425)?
Weekly Report · 04/28 12:06
Weekly Report: what happened at CNTB last week (0414-0418)?
Weekly Report · 04/21 12:05
More
About CNTB
Connect Biopharma Holdings Limited is a global clinical-stage biopharmaceutical company. The Company is focused on advancing rademikibart, a potentially best-in-class next generation anti-interleukin-4-receptor alpha (IL-4Rα) antibody, to transform acute and chronic care in asthma and chronic obstructive pulmonary disease (COPD). Its lead product candidate, rademikibart, is an antibody designed to target interleukin-4 receptor alpha (IL-4Rα) in development for the treatment of atopic dermatitis (AD) and asthma. As an inhibitor of IL-4Rα, rademikibart blocks inflammatory signaling by both IL-4 and IL-13. The Company has completed a global Phase II trial (CBP-201-WW001) of rademikibart in adult patients with moderate-to-severe AD.

Webull offers Connect Biopharma Holdings Ltd (ADR) stock information, including NASDAQ: CNTB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CNTB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CNTB stock methods without spending real money on the virtual paper trading platform.